Injury Illness Prevention Plan - Flipbook - Page 245
Health and Safety Program Manual
Teamwrkx
Construction, Inc.
Issue Date: 10/16/23
Revision Date: 10/16/23
Lead Exposure
Reference: B-4
The Company shall institute a medical surveillance program for all workers who are or may be exposed at or
above the action level (AL) for more than 30 days per year. Medical examinations and procedures shall be
performed by or under the supervision of a licensed physician.
When a worker’s airborne exposure is at or above the AL for more than 30 days in any consecutive 12 months,
an immediate medical consultation is required when the worker notifies The Company that they:
•
•
•
•
Has developed signs or symptoms commonly associated with lead-related disease
Has demonstrated difficulty in breathing during respirator use or a fit test
Desires medical advice concerning the effects of past or current lead exposure on the worker’s
ability to have a healthy child
Is under medical removal and has a medically appropriate need
The medical surveillance is provided without cost to the workers and consists of the following:
•
•
•
•
•
•
•
The name, social security number, and description of the duties of the worker
A copy of the physician's written opinions
Results of any airborne exposure monitoring done for that worker and the representative
exposure levels supplied to the physician
Any worker medical complaints related to exposure to lead
A copy of the medical examination results including medical and work history
A description of the laboratory procedures and a copy of any standards or guidelines used to
interpret the test results or references to that information
A copy of the results of biological monitoring
MEDICAL REMOVALS
Temporary medical removal can result from an elevated blood level or a written medical opinion. More
specifically, The Company is required to remove from work a worker with a lead exposure at or above the AL
each time periodic and follow-up (within two weeks of the periodic test) blood sampling tests indicate that the
worker’s blood level is at or above 50 μg /dl.
The Company shall remove workers with lead exposure at or above the AL each time a final medical
determination indicates that the worker needs reduced lead exposure for medical reasons. If the physician who
is implementing The Company’s medical program makes a final written opinion recommending the worker’s
removal or other special protective measures, The Company shall implement the physician’s recommendation.
For a worker removed from exposure to lead at or above the AL due to a blood lead level at or above 50 μg/dl,
The Company may return that worker to former job status when two consecutive blood sampling tests indicate
that the worker’s blood lead level is below 40 μg /dl.
20
